BioCentury
ARTICLE | Financial News

Cel-Sci completes direct public offering

March 10, 2017 7:58 PM UTC

Cancer and infectious disease company Cel-Sci Corp. (NYSE-M:CVM) raised $1.5 million through the sale of 15 million shares at $0.10 in a registered direct offering to institutional investors on March...

BCIQ Company Profiles

Cel-Sci Corp.